Real-World Data & Evidence Solutions
REAL-WORLD DATA
THIN®, The Health Improvement Network, is a large European databases network of Electronic Health Records. These data are transmitted by a network of voluntary physicians who firmly believe that supporting this kind of longitudinal data observatory benefits research and medical progress, in compliance with current regulations, including GDPR.
Cegedim Health Data provides access to precise, ethical, actionable longitudinal data from the THIN® databases. It works with researchers, health authorities, healthcare practitioners, pharma and medical devices companies. It supports them in several areas notably R&D, market access, medical affairs and marketing, with the aim of improving public health.
The THIN® databases are used by leading healthcare authorities and research centers, and also by academics for numerous scientific publications: more than 2.000 scientific papers have been published. THIN® therefore contributes to advancements in patient care, in the interests of public health.
THIN® offers immediate access to patient records, back from 2014.
THIN® solution benefits:
Population Health Management
- Research that facilitates the improvement of patient care across the general population
Primary Care Policy
- By using data to better inform health authorities about how primary care services can be delivered and targeted more effectively
Epidemiological Research
- Understanding trends in the presence or absence of diseases and disorders and their effects on society
REAL-WORLD EVIDENCE
We have a dedicated team of experts that can work in partnership with you and your team on customized projects to help you dig deeper to uncover answers and drive improvements in patient outcomes.
Market Access
- Real World Data (RWD) is able to provide direct insight into the current usage of medicines in order to generate Real-World evidence (RWE) to sustain product value proposition in the peer-reviewed literature, to facilitate reimbursement and Key Opinion Leader (KOL) adoption. When used in an evidence-generation strategy, Real-World evidence (RWE) can effectively communicate product value to the desired stakeholders.
Medical Affairs
- Real-World Data (RWD) provides grounds to understand the burden of disease, to enhance the value of therapies for the doctors who prescribe them, the health systems who ensure access to them, and the patients who depend on them.
Marketing
- Real-World Evidence (RWE) provides essential information for both prelaunch and post-launch studies, regarding prescription habits correlated to patients’ profile and pathologies.
Regulatory Affairs
- Information gathered from current medical practice represents the authentic evidence regarding drug safety and efficacy as assessed by pharmaco-economic indicators
ADVANCED ANALYTICS
Health Data Lab is our cloud-based solution for business intelligence and analytics with interactive dashboards and trend trackers. It was born from the belief that high-quality data, management, and insights are the keys to a better way of addressing current pathways, and trends and making significant improvements across the healthcare sector.
The Health Data Lab uses THIN® data, together with predefined calculations around aggregated data to understand market trends (Market Intelligence), or more bespoke analysis to answer specific questions about longitudinal patient information such as treatment pathways (Patient Intelligence).
Want to find out more?
If you’ve got a question, or would like more information about our products and services then get in touch.
